Basics Olema Pharmaceuticals, Inc. IPO Date: November 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $299.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 3.96% Avg Daily Range (30 D): $0.19 | 3.73% Avg Daily Range (90 D): $0.18 | 3.77% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .66M Avg Daily Volume (90 D): .77M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 93 Institutional Trades Total Inst.Trades: 711 Avg Inst. Trade: $1.72M Avg Inst. Trade (30 D): $1.03M Avg Inst. Trade (90 D): $1.84M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.1M Avg Closing Trade (30 D): $1.29M Avg Closing Trade (90 D): $1.39M Avg Closing Volume: 163.23K     News May 28, 2025 @ 11:00 AM Olema Oncology Announces Palazestrant Dose Selecti... Source: N/A Apr 30, 2025 @ 5:00 PM Metastatic HR+/HER2- Breast Cancer Market—T... Source: Delveinsight Apr 25, 2025 @ 5:00 PM Olema Oncology Announces New Preclinical Data for ... Source: N/A Jan 3, 2025 @ 9:30 PM Olema Oncology Reports Inducement Grants Under Nas... Source: N/A Jan 2, 2025 @ 12:00 PM Olema Oncology to Present at 43rd Annual J.P. Morg... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.9 $-.36 $-.4 Diluted EPS $-1.9 $-.36 $-.4 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -128.89M $ -30.39M $ -33.57M Operating Income / Loss $ -142.79M $ -34.87M $ -36.77M Cost of Revenue $ $ $ Net Cash Flow $ 16.92M $ -88.84M $ 103.59M PE Ratio